Navigation Links
Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS/SaaS Clinical Trials Collaboration Software
Date:8/1/2009

Terrosa Technologies, a provider of Cloud and SaaS migration services and SaaS based applications, announces it has exclusive world wide sales, marketing and distribution responsibilities with Integrated Clinical Solutions for its Inclinicalperform application. Inclinicalperform is software-as-a-subscription (SaaS) based collaboration Clinical Trial Management System (CTMS) tool for the pharmaceutical clinical research community to reduce both costs and effort in tracking, monitoring and aggregating information that is created during the clinical trials process.

Thousand Oaks, CA (PRWEB) August 1, 2009 -- Terrosa Technologies, a provider of Cloud and SaaS migration services and SaaS based applications, announces it has exclusive world wide sales, marketing and distribution responsibilities with Integrated Clinical Solutions for its inclinicalperform application. Inclinicalperform is software-as-a-subscription (SaaS) based collaboration Clinical Trial Management System (CTMS) tool for the pharmaceutical clinical research community to reduce both costs and effort in tracking, monitoring and aggregating information that is created during the clinical trials process.

With this agreement, Terrosa will have exclusive responsibility to for the sales and marketing of Integrated Clinical Solutions' Inclinicalperform Terrosa Technologies, LLC will develop the go-to-market strategies as well operations for sales, marketing and support for inclinicalperform This partnership expands on Terrosa's successful SaaS software conversion services and will speed time to market for independent software vendors (ISVs) such as Integrated Clinical Solutions. "We are pleased to partner with Integrated Clinical Solutions so that they may maintain their focus on further development and roadmap to incorporating new process automations within inclinicalperform" said Kim Terry, President of Terrosa Technologies.

inclinicalperform's collaboration software platform will benefit the clinical research community by taking much of the manual work out of tracking, monitoring and aggregating information that is created during the clinical trials process. "Our software makes the clinical operations job easier by providing a consistent collaborative work process that is straightforward and self documenting", said Inclinical's founder J. Peter Armerding, "Terrosa's integrated services will allow us to do what we do best - Clinical Operations Process Automation".

Terrosa Technologies (www.terrosatech.com) specializes in the migration of on premise applications into subscription based services to drive down costs and make high quality software more available to companies of all sizes. "Response for this type of comprehensive service has been tremendous because of the Return on Investment and Total Cost of Ownership benefits," states Terrosa President, Kim Terry. "We work with software companies who have domain expertise, turning them into SaaS providers with a powerful marketing and sales program."

About Terrosa Technologies:

Terrosa technology is an early innovator in working with software developers who need assistance to take their application to the SaaS environment and in providing go-to-market planning and Sales and Marketing operations. In addition, Terrosa Technologies also achieves positive results for our customers in transition in-house systems to Software as a Service delivered systems, Platform as a Service, or other technologies collectively known as Cloud Computing. Enormous efficiencies are expected to quickly drive down the cost of application programs for everyone using this technology.

About Integrated Clinical Solutions:

Integrated Clinical Solutions, Inc. (www.inclinical.com) creates software exclusively for clinical trial operations organizations. We bring process automation to clinical operations in the pharmaceutical, biotechnology and medical device industries. After encountering all the difficulties of implementing other leading clinical software programs, we realized that the cost of implementation and lost time for stakeholders to learn new programs was a large hurdle to overcome when you bring new systems online. We designed our software to be implemented quickly and easily understood by clinical operations end users.

###

Read the full story at http://www.prweb.com/releases/2009/08/prweb2702264.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing
2. Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic
3. Ricardo Launches Consortium to Evaluate Lubricant Challenges of Future Low Carbon Engine Technologies
4. BioSpecifics Technologies Corp. to Present at CapStone Investments Third Annual Small-Cap Investor Conference
5. DNA Software, Inc. Awarded $2.5 M in NIH Funding to Develop Pioneering Nucleic Acid-based Technologies
6. 4th BTLtec Conference on 24-25 Sep in Graz, Austria features Biomass to Liquids Innovators Sharing Updates on Pyrolysis and Gasification Technologies, Syngas Application, BTL Value Chain and a Site Visit to the Biomass CHP Gussing Plant.
7. Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing
8. Supelco(R) and MIP Technologies Launch New SPE Product for the Selective Extraction of NSAIDs From Environmental Water
9. ImmunoVaccine Technologies Licenses Immunotopes Breast, Ovarian and Prostate Cancer Antigens
10. Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing
11. Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS/SaaS Clinical Trials Collaboration Software
(Date:9/20/2017)... ... September 20, 2017 , ... Foresight Institute, ... and other transformative technologies, announced the winners for the 2017 Foresight Institute Feynman ... Theory in nanotechnology/molecular manufacturing. , Established in 1993 and named in honor of ...
(Date:9/19/2017)... ... 19, 2017 , ... VetStem Biopharma ’s CEO and founder, Dr. Bob Harman DVM, MPVM, ... book "Stem Cell Therapy: A Rising Tide". Dr. Harman and Dr. Riordan met in ... an interest in the potential of stem cell therapy and a fast friendship was formed. ...
(Date:9/19/2017)... ... September 19, 2017 , ... Molecular Devices, LLC, a leader ... to launch the CloneSelect™ Single-Cell Printer™ in North America. This novel system ... provide visual documentation of monoclonality for use in cell line development. , ...
(Date:9/18/2017)... Montrium , a growing leader in Electronic Trial Master file ... non-profit research organization, Multidisciplinary Association for Psychedelic Studies (MAPS). ... MAPS Public Benefit Corporation ... ... MDMA for the treatment of Posttraumatic Stress Disorder (PTSD). MAPS also ...
Breaking Biology Technology:
(Date:5/6/2017)... , May 5, 2017 RAM ... announced a new breakthrough in biometric authentication based ... quantum mechanical properties to perform biometric authentication. These new ... semiconductor material created by Ram Group and its ... entertainment, transportation, supply chains and security. Ram Group ...
(Date:4/13/2017)... April 13, 2017 UBM,s Advanced Design and ... will feature emerging and evolving technology through its 3D ... will run alongside the expo portion of the event ... and demonstrations focused on trending topics within 3D printing ... and manufacturing event will take place June 13-15, 2017 at ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
Breaking Biology News(10 mins):